Latest Breaking News On - Orphan drug designation - Page 1 : comparemela.com

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Christopher keenanChohee yunEuropean medicines agencyCorporate communicationsPliant therapeutics incDrug administrationClinical developmentSenior vice presidentPliant therapeuticsFast track designationOrphan drug designationMedia contactInvestor relations

The morning catch up: ASX to drop as US sharemarkets rise ahead of Federal Reserve decision

The morning catch up: ASX to drop as US sharemarkets rise ahead of Federal Reserve decision
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

Port hedlandWestern australiaUnited statesUnited kingdomSociete generaleDrug administrationRace oncology ltdFederal reserveEuropean unionSouthwest airlinesCredit agricoleMetals ltdYandal resources ltdRiversgold ltdAnson resources ltdDow jones

Pacylex Publishes Phase 1 Safety and Efficacy of Zelenirstat in Cancer Patients in the Journal Investigational New Drugs

Pacylex Publishes Phase 1 Safety and Efficacy of Zelenirstat in Cancer Patients in the Journal Investigational New Drugs
torontotelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from torontotelegraph.com Daily Mail and Mail on Sunday newspapers.

Reportable incPacylex pharmaceuticalsCure cancer foundationUs department of defensePacylex pharmaceuticals incCanada juneInvestigational newFirst in human phasei trialDaily oral zelenirstatN myristoyltransferase inhibitorAdvanced solid tumorsRefractoryb cell lymphomasHodgkin lymphomaOrphan drug designationFast track designation

Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia

Cellectis Receives Orphan Drug Designation for UCART22, its Allogeneic CAR T Product for Patients with Acute Lymphoblastic Leukemia
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNorth carolinaNew yorkFrance generalAshleyr robinsonArthur strilMark frattiniPascalyne wilsonPatricia sosa navarroAmerican society of hematologyCellectis the company euronext growthEuropean medicines agencyEuropean unionSecurities exchange commissionCommittee for orphan medicinal productsEuropean commission

NurExone Announces Voting Results from 2024 Annual Meeting

NurExone Announces Voting Results from 2024 Annual Meeting of Shareholders.

Province of albertaProvince of ontarioZiv haftYoram druckerLior shaltielOded orgilGadi riesenfeldJames jay richardsonEva reuterCompany or nurexoneExchange hold periodNurexone biologic incCompany commonCompany annual information formVenture exchangeThesis capital inc